GAMMA Investing LLC lifted its holdings in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 22,374.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 126,754 shares of the semiconductor company's stock after buying an additional 126,190 shares during the quarter. GAMMA Investing LLC owned approximately 0.39% of Silicon Laboratories worth $14,269,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the business. Jones Financial Companies Lllp grew its holdings in Silicon Laboratories by 44.5% in the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 69 shares during the period. Headlands Technologies LLC bought a new stake in shares of Silicon Laboratories in the 4th quarter worth approximately $70,000. Venturi Wealth Management LLC increased its position in Silicon Laboratories by 207.0% during the 4th quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company's stock valued at $98,000 after buying an additional 530 shares in the last quarter. Asset Management One Co. Ltd. purchased a new position in Silicon Laboratories during the fourth quarter valued at $117,000. Finally, O Shaughnessy Asset Management LLC bought a new stake in Silicon Laboratories in the fourth quarter worth $214,000.
Insiders Place Their Bets
In other news, SVP Robert J. Conrad sold 4,029 shares of the company's stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $131.20, for a total value of $528,604.80. Following the completion of the transaction, the senior vice president now owns 25,380 shares of the company's stock, valued at $3,329,856. This represents a 13.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Robert Matthew Johnson sold 5,879 shares of Silicon Laboratories stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $131.20, for a total value of $771,324.80. Following the sale, the chief executive officer now directly owns 73,688 shares in the company, valued at $9,667,865.60. This trade represents a 7.39% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,626 shares of company stock worth $1,509,319. Company insiders own 1.60% of the company's stock.
Silicon Laboratories Stock Performance
Shares of SLAB stock traded up $3.98 during mid-day trading on Tuesday, reaching $138.96. 525,533 shares of the company's stock traded hands, compared to its average volume of 340,923. The firm has a market capitalization of $4.53 billion, a PE ratio of -23.39 and a beta of 1.42. Silicon Laboratories Inc. has a 12 month low of $82.82 and a 12 month high of $160.00. The firm has a 50 day moving average price of $110.69 and a two-hundred day moving average price of $123.46.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.01. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business had revenue of $177.71 million during the quarter, compared to analyst estimates of $177.48 million. During the same quarter in the previous year, the company posted ($0.92) earnings per share. Silicon Laboratories's revenue for the quarter was up 67.0% on a year-over-year basis. As a group, equities analysts expect that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. Susquehanna lifted their price target on Silicon Laboratories from $100.00 to $110.00 and gave the stock a "neutral" rating in a research report on Wednesday, May 14th. Stifel Nicolaus decreased their price objective on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a report on Thursday, April 17th. Barclays reduced their price objective on Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a report on Tuesday, April 22nd. Benchmark reissued a "buy" rating and set a $160.00 price objective on shares of Silicon Laboratories in a report on Tuesday, May 27th. Finally, Wall Street Zen upgraded shares of Silicon Laboratories from a "sell" rating to a "hold" rating in a research report on Wednesday, May 14th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $126.50.
View Our Latest Stock Analysis on SLAB
Silicon Laboratories Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Read More

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report